Obniska J - Search Results

1

Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione.

Obniska J, Kołaczkowski M, Bojarski AJ, Duszyńska B. Obniska J, et al. Eur J Med Chem. 2006 Jul;41(7):874-81. doi: 10.1016/j.ejmech.2006.03.001. Epub 2006 Apr 4. Eur J Med Chem. 2006. PMID: 16600439

2

Synthesis and anticonvulsant properties of new N-piperazinylalkyl imides of succinic acid.

Obniska J, Kulig K, Zejc A. Obniska J, et al. Acta Pol Pharm. 1998 May-Jun;55(3):223-31. Acta Pol Pharm. 1998. PMID: 9735703 Free article.

3

Synthesis, physicochemical and anticonvulsant properties of new N-pyridyl derivatives of 3-phenyl- and 3,3-diphenyl-succinimides.

Obniska J, Zejc A, Karolak-Wojciechowska J. Obniska J, et al. Farmaco. 1999 Jul 30;54(7):423-9. doi: 10.1016/s0014-827x(99)00033-6. Farmaco. 1999. PMID: 10486909

After molecular modelling and quantum-chemistry calculations the theoretical activity test was applied (W. Kwiatkowski, J. Karolak-Wojciechowska, SAR and QSAR Envir. Res. 1 (1993) 233; Chem. Abstr. 120, 153001 (1994). J. Karolak-Wojciechowska, M. Blaszczyk, W. Kwiat …

After molecular modelling and quantum-chemistry calculations the theoretical activity test was applied (W. Kwiatkowski, J. Karolak-Wo …

4

Synthesis, 5-HT1A and 5-HT2A receptor affinity of new 1-phenylpiperazinylpropyl derivatives of purine-2,6- and pyrrolidine-2,5-diones.

Pawłowski M, Chłoń G, Obniska J, Zejc A, Charakchieva-Minol S, Mokrosz MJ. Pawłowski M, et al. Among authors: obniska j. Farmaco. 2000 Jun-Jul;55(6-7):461-8. doi: 10.1016/s0014-827x(00)00069-0. Farmaco. 2000. PMID: 11204747

5

Synthesis and anticonvulsant properties of new 1-phenyl and 1-phenylamino-3-phenylpyrrolidine-2,5-dione derivatives.

Obniska J, Zeic A, Zagórska A. Obniska J, et al. Acta Pol Pharm. 2002 May-Jun;59(3):209-13. Acta Pol Pharm. 2002. PMID: 12230248 Free article.

6

Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the pre-screening of 5-HT1A ligands.

Zajdel P, Bojarski AJ, Byrtus H, Chłoń-Rzepa G, Obniska J, Chevallet P, Martinez J, Pawłowski M. Zajdel P, et al. Among authors: obniska j. Biomed Chromatogr. 2003 Jul;17(5):312-7. doi: 10.1002/bmc.224. Biomed Chromatogr. 2003. PMID: 12884396

7

Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.

Obniska J, Pawłowski M, Kołaczkowski M, Czopek A, Duszyńska B, Klodzińska A, Tatarczyńska E, Chojnacka-Wójcik E. Obniska J, et al. Pol J Pharmacol. 2003 Jul-Aug;55(4):553-7. Pol J Pharmacol. 2003. PMID: 14581713 Free article.

8

Synthesis and anticonvulsant properties of new N-[(4-arylpiperazin-1-yl)-methyl] derivatives of 3-aryl pyrrolidine-2,5-dione and 2-aza-spiro[4.4]nonane-1,3-dione.

Obniska J, Zagorska A. Obniska J, et al. Farmaco. 2003 Dec;58(12):1227-34. doi: 10.1016/S0014-827X(03)00187-3. Farmaco. 2003. PMID: 14630232

9

Synthesis, physicochemical and anticonvulsant properties of some n-substituted amides of 3-spirocycloalkylpyrrolidine-2,5-dione.

Obniska J, Zejc A. Obniska J, et al. Acta Pol Pharm. 2003 Sep-Oct;60(5):383-90. Acta Pol Pharm. 2003. PMID: 15005422 Free article.

10

Synthesis and anticonvulsant properties of a series of N-substituted 2-aza-spiro[4.5]decane-1,3-diones and 8-phenyl-2-aza-spiro[4.5]decane-1,3-diones.

Obniska J. Obniska J. Acta Pol Pharm. 2004 Nov-Dec;61(6):467-72. Acta Pol Pharm. 2004. PMID: 15794340 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters